Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BICO Group ABCLLKF 63 12-1 Month Momentum % is -55.40% as of Aug. 01, 2026. GuruFocus rates CLLKF with a GF Score™ of 63/100 and a GF Value™ of $3.68 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 824 Medical Devices & Instruments companies, BICO Group AB ranks worse than 87.86% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-01), BICO Group AB's 12-1 Month Momentum % is -55.40%.
The industry rank for BICO Group AB's 12-1 Month Momentum % or its related term are showing as below:
CLLKF's 12-1 Month Momentum % is ranked worse than 87.86% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: -17.81
vs CLLKF: -55.40
BICO Group AB (OTCPK:CLLKF) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
BICO Group AB 12-1 Month Momentum % Related Terms
CLLKF vs ABT, SYK, MDT: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, BICO Group AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where BICO Group AB's 12-1 Month Momentum % falls into.
BICO Group AB (OTCPK:CLLKF) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -55.40% mean?
BICO Group AB (CLLKF) has a 12-1 Month Momentum % of -55.40% as of Aug. 01, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on BICO Group AB and its competitors. According to the industry distribution chart, BICO Group AB ranks #724 out of 824 companies in the Medical Devices & Instruments industry, placing it in the top 87.9%.
Is BICO Group AB's 12-1 Month Momentum % too high?
BICO Group AB's current 12-1 Month Momentum % is -55.40%. Based on the distribution chart, BICO Group AB ranks #724 out of 824 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BICO Group AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's 12-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #724 out of 824 companies for 12-1 Month Momentum %. This places BICO Group AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on BICO Group AB and its competitors. BICO Group AB's current 12-1 Month Momentum % is -55.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.68, compared to a current price of $1.53 — trading 58.4% below its estimated fair value. The current 12-1 Month Momentum % is -55.40%. BICO Group AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current 12-1 Month Momentum % is -55.40% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CLLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of $1.53 is trading 58.4% below its estimated GF Value™ of $3.68.
GuruFocus considers BICO Group AB to be Possible Value Trap.
Key valuation signals for CLLKF:
12-1 Month Momentum %: -55.40%
GF Value™: $3.68 vs. price of $1.53 (58.4% below fair value)
No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
63GF Score
Get the complete analysis for CLLKF
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLLKF has been successfully added to your 
